GridAI Technologies (GRDX) vs Rockwell Medical (RMTI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
GridAI Technologies (GRDX) has outperformed Rockwell Medical (RMTI) over the past year, gaining 0.0% versus a loss of 30.9%. Over five years, RMTI leads with a -87.5% price change compared with -100.0% for GRDX. GridAI Technologies is the larger company by market cap ($34.2 million vs $32.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GRDX | RMTI |
|---|---|---|
| Share price | $4.80 | $8.02 |
| Market cap | $34.23M | $32.32M |
| 1-day change | +16.50% | -2.43% |
| YTD return | -11.59% | -0.96% |
| 1-year return | 0.00% | -30.92% |
| 5-year return | -99.99% | -87.55% |
| Forward P/E | — | 114.57 |
| EPS (TTM) | $-5.65 | $-1.34 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.93 | $12.90 |
| 52-week low | $1.87 | $4.89 |
| Distance from 52-week high | -30.73% | -37.83% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +149.38% |
| Average volume | 101.84K | 26.80K |
| Shares outstanding | 7.13M | 4.03M |
| Employees | — | 157 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GRDX has outperformed RMTI by 30.9 percentage points over the past year.
About GridAI Technologies
GRDX stock →GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency.
Healthcare · Biotechnology
About Rockwell Medical
RMTI stock →Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers.
Healthcare · Drug Manufacturers - Specialty & Generic · 157 employees
GRDX vs RMTI FAQ
Which is bigger, GridAI Technologies or Rockwell Medical?
GridAI Technologies (GRDX) is larger, with a market capitalization of $34.23M compared with $32.32M for Rockwell Medical (RMTI).
Which stock has performed better over the past year, GRDX or RMTI?
GRDX returned 0.00% over the past 12 months, compared with -30.92% for RMTI (price return, excluding dividends). Past performance does not predict future results.
Are GridAI Technologies and Rockwell Medical in the same industry?
Both are in the Healthcare sector, but in different industries: Biotechnology for GridAI Technologies and Drug Manufacturers - Specialty & Generic for Rockwell Medical.